Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 83639
                    [Title] => New osteoarthritis clinical trial okays anti-inflammatory drug
                    [Summary] => PRAGUE – In a unique managed care clinical trial, Mobic (meloxicam), designed to relieve the signs and symptoms of osteoarthritis, showed significantly greater "patient success" than other commonly used prescription nonsteroid anti-inflammatory drugs (NSAIDs).


The randomized study, which compared Mobic to "usual care," or whatever prescription-NSAID patients’ individual physicians selected as their osteoarthritis treatment, was presented for the first time at the Annual European Congress of Rheumatology in this city. 


                    [DatePublished] => 2001-07-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

EVERYDAY CARE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 83639
                    [Title] => New osteoarthritis clinical trial okays anti-inflammatory drug
                    [Summary] => PRAGUE – In a unique managed care clinical trial, Mobic (meloxicam), designed to relieve the signs and symptoms of osteoarthritis, showed significantly greater "patient success" than other commonly used prescription nonsteroid anti-inflammatory drugs (NSAIDs).


The randomized study, which compared Mobic to "usual care," or whatever prescription-NSAID patients’ individual physicians selected as their osteoarthritis treatment, was presented for the first time at the Annual European Congress of Rheumatology in this city. 


                    [DatePublished] => 2001-07-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

New osteoarthritis clinical trial okays anti-inflammatory drug

July 9, 2001 - 12:00am

PRAGUE – In a unique managed care clinical trial, Mobic (meloxicam), designed to relieve the signs and symptoms of osteoarthritis, showed significantly greater "patient success" than other commonly...

Science and Environment